Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Solid Neoplasm × Mitozytrex × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Solid Neoplasm 1

Interventions

veliparib 1 tipifarnib 1 pazopanib 1 Mitozytrex 1 Mitomycin 1 Immunoglobulin G 1 Erlotinib Hydrochloride 1 Disulfides 1 Bevacizumab 1 ARQ 197 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01017640 2016-07-11

Veliparib With or Without Mitomycin C in Treating Patients With Metastatic, Unresectable, or Recurrent Solid Tumors

National Cancer Institute (NCI)

Phase 1 Completed

Solid Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon ⚡